Stankevicius.com puts another short on Bitcoin expecting the price to hit $10,000 by November

EQS Newswire / 12/09/2022 / 17:20 UTC+8 Stankevicius.com puts another short on Bitcoin expecting the price to hit $10,000 by November   New York, SAIB: Stankevicius Alternative Investment Banking (stankevicius.com) opened another short position and is expecting a price drop to as low as $10,000 by November mid.   Earlier…

Eisai and Merck & Co., Inc. Present Results from Phase 3 LEAP-002 Trial Evaluating LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Versus LENVIMA Monotherapy in Patients With Unresectable Hepatocellular Carcinoma

TOKYO and RAHWAY, N.J., Sep 12, 2022 - (JCN Newswire via SEAPRWire.com) - Eisai and Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside of the United States and Canada) today announced the first presentation of results from the final analysis of the Phase 3 LEAP-002 trial investigating…

AVIA Releases OTT Study in Singapore at its First OTT Upfront Showcase Presenting Premium Content at its Best

Singapore, Sep 12, 2022 - (ACN Newswire via SEAPRWire.com) - The Asia Video Industry Association (AVIA) has released a new research study entitled Premium OTT - Building its Rightful Place in the Digital Market, to understand the usage of different video services in Singapore and attitudes towards them. The independent…

Eisai Presents Results of Post Hoc Analysis of Eribulin Mesylate (HALAVEN) at the European Society for Medical Oncology (ESMO) Congress 2022

TOKYO, Sep 12, 2022 - (JCN Newswire via SEAPRWire.com) - Eisai Co., Ltd. announced today results from a post hoc analysis of three randomized, pivotal, Phase 3 studies (EMBRACE trial/Study 305, Study 301 and Study304) evaluating the efficacy of eribulin mesylate (marketed as HALAVEN) versus other chemotherapies (Treatment of Physician's…

Indonesia’s Bio Farma ready to produce ‘IndoVac’ Covid-19 vaccines

BANDUNG, INDONESIA, Sep 12, 2022 - (ACN Newswire via SEAPRWire.com) - PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in manufacturing IndoVac, its Covid-19 vaccines brand, including primary series vaccines, booster vaccines and vaccines for children, in development since November 2021.IndoVac Covid-19…